The global protein labeling market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.1% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 2.6 Billion |
Market Forecast in 2033 | USD 6.0 Billion |
Market Growth Rate (2025-2033) | 9.1% |
Protein labeling refers to the covalent attachment of different molecules, such as biotin, reporter enzymes, fluorophores, and radioactive isotopes, to the target nucleotide sequence. It is achieved by the method of fluorescent fusions, ligases, and self-labeling tags. Nowadays, advanced imaging approaches are adopted to obtain detailed information on the spatial organization and conformational dynamics of individual proteins. As a result, the application of protein labeling is expanding in biological research worldwide to facilitate the detection or purification of the labeled protein and its binding partners.
The rising utilization of bioengineering technologies represents one of the major factors positively influencing the demand for protein labeling in the healthcare sector. Protein labeling is widely used for biological process monitoring, simplifying detection workflows, reliable quantification of compounds, and specific detection of protein modifications and isoforms in multiplexed samples. Moreover, researchers across the globe are focusing on improving the accuracy, resolution, and procedures of protein labeling techniques to offer an alternative to fluorescent proteins. These technologies are also used to study the function and localization of proteins in living and fixed cells. This, in confluence with the growing prevalence of chronic and lifestyle diseases, is strengthening the market growth. Apart from this, several drugs are in the research and development (R&D) phase. This, along with the increasing adoption of modern molecular tools to enhance the functional mechanisms in drug development, diagnosis, and therapy applications, is anticipated to impel the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein labeling market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on labeling method, product, and application.
Breakup by Labeling Method:
Breakup by Product:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cytiva (Danaher Corporation), F. Hoffmann-La Roche Ltd. (Roche Holding AG), Jena Bioscience GmbH, LGC Limited, LI-COR Inc., Merck KGaA, New England Biolabs, PerkinElmer Inc., Promega Corporation and Thermo Fisher Scientific Inc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Labeling Method, Product, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agilent Technologies Inc., Cytiva (Danaher Corporation), F. Hoffmann-La Roche Ltd. (Roche Holding AG), Jena Bioscience GmbH, LGC Limited, LI-COR Inc., Merck KGaA, New England Biolabs, PerkinElmer Inc., Promega Corporation and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
We expect the global protein labeling market to exhibit a CAGR of 9.1% during 2025-2033.
The rising adoption for protein labeling process to detect various proteins in tissues, cells, and biochemical assays, is primarily driving the global protein labeling market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for protein labeling process in drug development, diagnosis, and therapy applications of the coronavirus infection.
Based on the labeling method, the global protein labeling market can be bifurcated into in-vitro labeling and in-vivo labeling. Currently, in-vitro labeling holds the majority of the total market share.
Based on the product, the global protein labeling market has been segmented into reagents, kits, and services. Among these, reagents currently exhibit a clear dominance in the market.
Based on the application, the global protein labeling market can be divided into cell-based assays, fluorescence microscopy, mass spectrometry, immunological techniques, and protein microarray. Currently, immunological techniques account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global protein labeling market include Agilent Technologies Inc., Cytiva (Danaher Corporation), F. Hoffmann-La Roche Ltd. (Roche Holding AG), Jena Bioscience GmbH, LGC Limited, LI-COR Inc., Merck KGaA, New England Biolabs, PerkinElmer Inc., Promega Corporation, and Thermo Fisher Scientific Inc.